Related Experiment Videos
Hyperbaric oxygen therapy for severe ulcerative colitis.
A L Buchman1, C Fife, C Torres
1Division of Gastroenterology and Hepatology, Northwestern University Medical School, Chicago, Illinois 60611, USA. a-buchman@nwu.edu
Journal of Clinical Gastroenterology
|October 6, 2001
Summary
Hyperbaric oxygen therapy offers a new treatment for ulcerative colitis. This approach successfully induced clinical remission in patients resistant to standard therapies, allowing for corticosteroid withdrawal.
Area of Science:
- Gastroenterology
- Hyperbaric Medicine
Background:
- Ulcerative colitis is a chronic inflammatory bowel disease.
- Refractory cases often require advanced treatment strategies.
Observation:
- Hyperbaric oxygen therapy (HBOT) has previously shown success in perineal Crohn's disease.
- This study explores HBOT for ulcerative colitis refractory to conventional treatments.
Findings:
- Thirty HBOT sessions (100% oxygen at 2.0 atm absolute) were administered.
- Clinical remission was achieved, confirmed by Truelove-Witts and disease activity index scores.
- Successful tapering of corticosteroid medication was possible post-remission.
Implications:
- HBOT presents a potential therapeutic option for severe, treatment-resistant ulcerative colitis.
- Further research into HBOT mechanisms and long-term outcomes in ulcerative colitis is warranted.